BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 790746)

  • 41. Oxybutynin chloride in control of post-trasurethral vesical pain and spasm.
    Paulson DF
    Urology; 1978 Mar; 11(3):237-8. PubMed ID: 345586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological management of common urodynamic problems.
    Milroy E
    Urol Clin North Am; 1979 Feb; 6(1):265-72. PubMed ID: 34915
    [No Abstract]   [Full Text] [Related]  

  • 43. Urodynamic evaluation in primary enuresis: an investigative and treatment outcome correlation.
    Sehgal R; Paul P; Mohanty NK
    J Trop Pediatr; 2007 Aug; 53(4):259-63. PubMed ID: 17496326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analogues of oxybutynin. Synthesis and antimuscarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds.
    Carter JP; Noronha-Blob L; Audia VH; Dupont AC; McPherson DW; Natalie KJ; Rzeszotarski WJ; Spagnuolo CJ; Waid PP; Kaiser C
    J Med Chem; 1991 Oct; 34(10):3065-74. PubMed ID: 1920357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction.
    McGuire EJ; Savastano JA
    J Urol; 1984 Oct; 132(4):713-5. PubMed ID: 6147423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxybutynin: a new drug with analgesic and anticholinergic properties.
    Diokno AC; Lapides J
    J Urol; 1972 Aug; 108(2):307-9. PubMed ID: 5047425
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of the unstable bladder in children with the anticholinergic agent propiverin hydrochloride (mictonorm/mictonets)].
    Otto-Unger G
    Z Urol Nephrol; 1985 Mar; 78(3):145-52. PubMed ID: 4002894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
    López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
    Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholinergic and adrenergic neuroreceptors in urinary tract of female dogs. Evaluation of function with pharmacodynamics.
    Khanna OP; Heber D; Gonick P
    Urology; 1975 May; 5(5):616-23. PubMed ID: 236615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Anatomical, functional, clinical and therapeutic aspects of syndromes involving urogenital spasm and pain].
    Ferulano O; De Rosa G; Siconolfi M
    Minerva Urol; 1979; 31(1):39-52. PubMed ID: 38388
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of gabapentin and anticholinergics in management of neurogenic bladder after repair of spina bifida - a randomized controlled study.
    Dash V; Bawa M; Mahajan JK; Kanojia RP; Samujh R; Rao KL
    J Pediatr Surg; 2016 Dec; 51(12):2025-2029. PubMed ID: 27680597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro study of antispasmodic effects of dicyclomine hydrochloride on vesicourethral smooth muscle of guinea pig and rabbit.
    Khanna OP; DiGregorio GJ; Barbieri EJ; McMichael R; Ruch E
    Urology; 1979 Apr; 13(4):457-62. PubMed ID: 433063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uropharmacology: part VI. Parasympathetic depressants.
    Finkbeiner AE; Bissada NK; Welch LT
    Urology; 1977 Nov; 10(5):503-10. PubMed ID: 21482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoscopic suspension of the vesical neck in massive urethral dilatation.
    Fowler JE
    J Urol; 1978 Apr; 119(4):573-4. PubMed ID: 565827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacious and relatively simple method of rehabilitation of the bladder in the early stages of paraplegia or tetraplegia-results (author's transl)].
    van Laere M; Siron G
    J Belge Med Phys Rehabil; 1978; 1(1):47-55. PubMed ID: 757416
    [No Abstract]   [Full Text] [Related]  

  • 57. Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients.
    Connor JP; Betrus G; Fleming P; Perlmutter AD; Reitelman C
    J Urol; 1994 Apr; 151(4):1045-7. PubMed ID: 8126787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preliminary report on the effect of distigmine bromide on the neurogenic bladder.
    Yeo J; Southwell P; Hindmarsh E
    Med J Aust; 1973 Jan; 1(3):116-20. PubMed ID: 4690345
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of neurogenic bladder using phenoxybenzamine and bethanechol in acute spinal cord lesions].
    Martínez Agulló E; Gallego Gómez J; Jiménez Cruz F; Gracia Pérez A
    Actas Urol Esp; 1983; 7(1):23-8. PubMed ID: 6136159
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacologic modification of therapeutic measures used in managing the neurogenic bladder.
    Schoenberg HW; Shah JP; Gregory JG
    Birth Defects Orig Artic Ser; 1977; 13(5):123-31. PubMed ID: 588676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.